EXR
46
2
PM
54
4
GS
76
4
GOOG
67
4
SEE
46
2
FLS
69
5
PX
63
3
AVB
54
4
FLR
66
11
ILMN
61
-4
SLB
52
6
EW
30
-2
OKE
52
3
JWN
67
2
WEC
51
6
ADM
30
2
VMC
63
10
HRL
30
3
ROST
52
2
NWSA
54
2
EXR
46
2
PM
54
4
GS
76
4
GOOG
67
4
SEE
46
2
FLS
69
5
PX
63
3
AVB
54
4
FLR
66
11
ILMN
61
-4
SLB
52
6
EW
30
-2
OKE
52
3
JWN
67
2
WEC
51
6
ADM
30
2
VMC
63
10
HRL
30
3
ROST
52
2
NWSA
54
2
Financhill
Back

Mondelez International Vs. Kymera Therapeutics Industry Stock Comparison

Sell
38

MDLZ
Mondelez International

Last Price:
71.12
Seasonality Move:
4.41%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
38
Mondelez International (MDLZ) is a Sell

Is Mondelez International a Buy, Sell or Hold?

  • The current Mondelez International [MDLZ] share price is $71.91. The Score for MDLZ is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • MDLZ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MDLZ Stock Price Chart

What is Mondelez International's stock price today?

  • The Mondelez International share price today is $71.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MDLZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

MDLZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.5 Sell
Relative Strength Index (14 RSI): 47.32 Sell
Chaikin Money Flow: 2464614 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.36 - 74.74) Sell
Bollinger Bands (100): (66.47 - 72.87) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

MDLZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.12 Buy
20-day SMA: 72.55 Sell
50-day SMA: 72.43 Sell
200-day SMA: 70.65 Buy
8-day EMA: 71.48 Buy
20-day EMA: 72.12 Sell
50-day EMA: 71.85 Buy
200-day EMA: 70.48 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Mondelez International Earnings Growth & MDLZ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.09 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Mondelez International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):